NCT01819415View on ClinicalTrials.gov

Omega-3 Supplementation and Vitreal VEGF Levels in Wet-AMD

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

February 28, 2013

Conditions
Exudative Age Related Macular Degeneration
Interventions
DIETARY_SUPPLEMENT

Anti-VEGF plus AREDS-2

Omega-3 metabolites supplementation

DIETARY_SUPPLEMENT

Anti-VEGF plus AREDS-1

Patients receiving intravitreal anti-VEGF and AREDS-1 supplementation plus Lutein, without Omega-3.

Trial Locations (1)

H1T2M4

Maisonneuve Rosemont Hospital, Montreal

Sponsors
All Listed Sponsors
collaborator

Fonds de recherche en ophtalmologie de l'Université de Montréal

OTHER

collaborator

Foundation Fighting Blindness

OTHER

collaborator

Retina Foundation of Canada

UNKNOWN

collaborator

Insight Instruments

UNKNOWN

collaborator

Synergetics Inc

UNKNOWN

collaborator

Novartis

INDUSTRY

lead

Maisonneuve-Rosemont Hospital

OTHER